Bought $1,000 of CSL shares 10 years ago? Here’s how much dividend income you’ve received

The CSL Limited (ASX: CSL) share price has outperformed the broader market over the last 12 months. The stock has fallen 1% since this time last year while the S&P/ASX 200 Index (ASX: XJO) has dropped 4%.

But the CSL share price’s domination of the index isn’t new. Over the last 10 years, the biotechnology giant’s shares have gained a whopping 433%. For comparison, the ASX 200 has lifted a respectable 52% in that time.

If one were to have invested $1,000 in CSL shares in January 2013, they likely would have walked away with 19 securities and around $13 change, paying $51.95 per share.

Today, that parcel would be worth a whopping $5,263. The CSL share price is currently $277.  

But that’s not all.

Let’s dive into the dividends our figurative long-term investor may have received over the life of their investment.

How much have CSL shares paid in dividends in 10 years?

Here are all the dividends offered by CSL over the decade just been, rounded to the nearest cent:

Over the last 10 years, our figurative investor has likely received $21.39 per CSL share they’ve held – a total of $406.41 of passive income.

That’s certainly nothing to scoff at. Indeed, dividends alone have returned almost 40% of their purchase price. It also bumps their total return on investment (ROI) to a whopping 474%.

And of course, that could have been higher if they compounded their returns by reinvesting their dividends.

CSL shares currently trade with a modest 1.1% dividend yield.

The post Bought $1,000 of CSL shares 10 years ago? Here’s how much dividend income you’ve received appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• How different is the Vanguard Australian Shares Index ETF (VAS) now compared to a year ago?
• Are healthy returns on the horizon for ASX 200 healthcare shares in 2023?
• I’d listen to Warren Buffett and invest in ASX shares with wide economic moats
• Build a strong portfolio in 2023 with these ASX 200 blue chip shares: experts
• Are these the best ASX 200 shares to buy and hold?

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/q4Zd7A5